The Ministry of Health It seems that he is clear: they are not going to vaccinate those under 60 years of age with AstraZeneca. This is stated in the new update of the vaccination plan by which condemn oblivion to 2,586,548 doses of the vaccine Anglo-Swedish pharmacist. Vials that Spain has already bought, but that have no addressee.

The accounts are as follows. Spain has agreed to purchase a total of 12,232,200 doses until the third quarter of the year (according to the Health report). At the moment, 3,337,398 of those doses have been placed, among people aged 60 to 69 years and essential professionals vaccinated with AstraZeneca (before the vaccine was paralyzed in those under 60 years).

Thus, Spain has a surplus of 8,894,802 doses to vaccinate the 3,154,127 Spaniards from among 60 to 69 years that there is still to put the first dose or finish immunizing with the second. To immunize all of them would require two doses or, what is the same, 6,308,254.

With these accounts, they remain pending 2,586,548 doses that would not have addressee Therefore, according to the vaccination protocol of the Ministry of Health, this vaccine can only be inoculated to people between 60 and 69 years old, who would already be covered with the aforementioned doses.

At the moment, it is not known where this supposed surplus of vaccines would be used, although the option remains that they serve to cover those under 60 who are already vaccinated with the first dose.

The option of ending the immunization with the same preparation is what the European Medicines Agency (EMA) and what other countries like the UK are doing. But it is not what Sanidad wants.

This same week, to questions from EL ESPAÑOL, Minister Carolina Darias placed all her hopes on a trial led by the Carlos III Institute to combine the doses of Pfizer and AstraZeneca.

In fact, the own Interterritorial Council of the National Health System has rejected the plan of Madrid and Andalusia so that those vaccinated with AstraZeneca under 60 years of age can get the second dose with the same pharmaceutical brand voluntarily.

‘No’ to volunteers

The proposal was raised by autonomous communities such as Andalusia or Madrid to prevent an inoculation of the second doses to that population, continuing with the agreed commercial house. But Sanidad said no.

Specifically, it does not “seem appropriate” to offer the Vaxzevria vaccine (AstraZeneca) to people under 60 years of age who “voluntarily want to be vaccinated”. They pointed out that this would create a “contradiction with the ethical principles on which the strategy itself is based.”

According to the Health document, in Spain there are almost 1 million vaccinated with the first dose of AstraZeneca who belong to priority groups (teachers, bodies and state security forces, etc).

For them, if they are under 60 years old, three options are assumed: a second dose from the same commercial house, combine with other vaccines (although there are no clinical studies to support possible efficacy yet) or leave the population with a single dose, which does not ensure immunity.


Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more